Drug interactions
Arformoterol + Sunitinib
Severity: Moderate
Arformoterol and Sunitinib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sunitinib can prolong the QT interval, and long-acting beta-agonists like arformoterol may cause tachycardia, hypokalemia and QT prolongation. The combination may increase arrhythmia risk.
What this interaction means in plain words
Arformoterol and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Arformoterol belongs to Respiratory; Sunitinib belongs to Oncology.
Why it happens
Additive pharmacodynamic QT prolongation, with beta-agonist-induced hypokalemia contributing.
What to do
Monitor ECG and serum potassium, especially in patients with cardiac disease or other QT-prolonging drugs. Correct electrolyte abnormalities promptly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Arformoterol and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Sunitinib
- Adagrasib + Sunitinib Major
- Amiodarone + Sunitinib Major
- Amisulpride + Sunitinib Major
- Anagrelide + Sunitinib Major
- Apalutamide + Sunitinib Major
- Arsenic trioxide + Sunitinib Major
Other interactions of Arformoterol
Frequently asked questions
Can I take Arformoterol with Sunitinib?
MediHelp rates the interaction as moderate. Arformoterol and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sunitinib can prolong the QT interval, and long-acting beta-agonists like arformoterol may cause tachycardia, hypokalemia and QT prolongation. The combination may increase arrhythmia risk.
How serious is the interaction between Arformoterol and Sunitinib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and serum potassium, especially in patients with cardiac disease or other QT-prolonging drugs. Correct electrolyte abnormalities promptly.
What other medicines interact with Sunitinib?
MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
